FTSE 250 movers: Hikma Pharmaceuticals hit by target price cut
17th Apr 2013 15:19
Hikma Pharmaceuticals was a heavy faller today after going ex-dividend and being hit by a target price cut from Jefferies, from 1,150p to 1,040p. The cut came after the group announced its plan to hold on to its global injectables business. Miners were under the weather as investors looked to inves
Read moreLondon midday: FTSE 100 on track for fourth straight loss
17th Apr 2013 11:39
A number of heavyweight stocks going ex-dividend assured that London's FTSE 100 index was in the red for a fourth consecutive day on Wednesday, while concerns over the global economy continued to weigh on sentiment. Global growth fears have hit markets over the last few days after a surprise slowdo
Read moreBroker tips: Tesco, Burberry, Hikma
17th Apr 2013 11:24
Panmure Gordon has maintained its 'buy' rating and 440p target price for supermarket group Tesco, highlighting a 'welcome shift in strategy' following the firm's full-year results. Panmure reckons that Tesco is on track in the UK and expects the recovery to "slowly emerge" this year and said that i
Read moreBroker snap: Jefferies cuts target for Hikma but stays upbeat
17th Apr 2013 11:16
Jefferies has cut its price target for pharmaceuticals firm Hikma from 1,150p to 1,040p after the company's decision to hold on to its global injectables business. Hikma said on Wednesday that it has seen a "significant amount of interest" in the injectables business by third parties. However, the
Read moreHikma Pharmaceuticals decides not to sell Injectables business
17th Apr 2013 08:37
FTSE 250-listed company Hikma Pharmaceuticals has announced that following the conclusion of its strategic review of its global Injectables business, it has decided that the business should remain part of the Hikma Group. The reason behind the decision is that it sees the business as holding a uni
Read moreWednesday broker round-up UPDATE
17th Apr 2013 07:20
African Barrick Gold: Deutsche Bank cuts target price from 230p to 173p, while its hold recommendation is reiterated. Ashmore Group: Morgan Stanley raises target price from 395p to 444p and maintains an equal-weight rating. Ashtead Group: Jefferies increases target price from 615p to 690o and reit
Read moreThursday broker round-up UPDATE
14th Mar 2013 07:11
Amara Mining: After having been under review, Cantor Fitzgerald reinitiates coverage with a price target of 81p and a buy recommendation. Antofagasta: Citigroup shifts target price from 990p to 1000p, but retains its sell recommendation. Ashtead Group: Investec raises target price from 475p to 700
Read moreLondon open: Ex-div stocks weigh on FTSE 100 early on
13th Mar 2013 08:33
Traders chose to take profits on Wednesday morning, taking advantage of the strong gains seen in previous sessions, with the FTSE 100 pulling back sharply from five-year highs. So far this year, the index has gained nearly 10% and is trading near levels not seen since late 2007. According to Reute
Read moreRevenue growth at Hikma to slow down after strong year
13th Mar 2013 07:19
Pharmaceuticals group Hikma registered an impressive increase in revenue in 2012, helped by strong performances from both the Branded and Injectables divisions, but warned that sales growth would slow this year. After the 20.8% growth seen in 2012, the company said that the rate would reduce to ar
Read moreMonday broker round-up UPDATE
4th Mar 2013 07:12
Aggreko: JP Morgan takes target price from 1845p to 1870p, while reiterating a neutral rating. Anglo American: Nomura reduces target price from 1800p to 1700p and downgrades from neutral to reduce. ARM Holdings: Deutsche Bank increases target price from 400p to 445p, but still recommends selling.
Read moreLondon close: Strong US data prompts late rally...again
1st Mar 2013 17:13
For a third day in a row, the FTSE 100 index rallied in afternoon trade on the back of strong economic figures from America, as investors temporarily shrugged off concerns about the automatic spending cuts which kick in later today. US President Barack Obama met with congressional leaders this afte
Read moreFTSE 250 movers: Hikma soars on 'unsolicited enquiries'
1st Mar 2013 15:23
Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future, prompting a strong rise in the share price. High Street betting shop William Hill jumped after announcing th
Read moreHikma Pharma shares rise on 'unsolicited enquiries'
1st Mar 2013 11:42
Hikma Pharmaceuticals on Friday confirmed that it has received several unsolicited enquiries in its Injectables business and is now undertaking a review of strategic options for its future. In a statment the group's Chief Executive Officer said: "We have received a number of unsolicited expression
Read moreThursday broker round-up UPDATE
28th Feb 2013 07:19
AZ Electronic Materials: Goldman Sachs moves target price from 440p to 450p and retains a buy recommendation. Bovis Homes Group: Deutsche Bank shifts target price from 667p to 679p, while downgrading to hold. British American Tabacco: Investec places its target price (previously 3350p) and buy rec
Read moreThursday broker round-up UPDATE
14th Feb 2013 08:09
African Barrick Gold: Deutsche Bank cuts target price from 410p to 340p, while staying with its hold recommendation. Investec reduces target price from 405p to 315p and downgrades from buy to hold. JP Morgan lowers target price from 370p to 290p and downgrades to underweight. AG Barr: Barclays down
Read more